Literature DB >> 21251486

Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009.

S Jefferies1, D Earl, N Berry, T Blackmore, S Rooker, N Raymond, A Pritchard, M Weatherall, R Beasley, K Perrin.   

Abstract

There is uncertainty whether the 2009 seasonal influenza vaccination influences the risk of infection with the 2009 pandemic influenza A(H1N1) virus. This issue was investigated in 548 healthcare workers from Capital and Coast District Health Board, Wellington, New Zealand, presenting with influenza-like illness during the influenza pandemic between June and August 2009. All workers completed an assessment sheet and had a nasopharyngeal swab tested by real-time RT-PCR. The risk of pandemic influenza A(H1N1) infection associated with the 2009 seasonal inactivated trivalent influenza vaccine was determined by logistic regression, with adjustment for potential confounding variables. In 96 workers pandemic influenza A(H1N1) RNA was detected and 452 tested negative. The multivariate analysis did not show any effect of vaccination on PCR-confirmed influenza A(H1N1)2009 infection (odds ratio 1.2, 95% confidence interval 0.7–1.9, p=0.48). We conclude that 2009 seasonal influenza vaccination had no protective effect against influenza A(H1N1)2009 infection amongst healthcare workers. To protect against further waves of the current pandemic influenza or future pandemics in which the influenza virus is antigenically distinct from contemporary seasonal influenza viruses, it would be necessary to vaccinate with a specific pandemic influenza vaccine, or a seasonal influenza vaccine that includes the pandemic influenza serotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251486

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

Review 1.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

2.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 3.  Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.

Authors:  Zhi-yuan Li; Jin-yan Chen; Yan-ling Zhang; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers.

Authors:  Ben Hudson; Les Toop; Dee Mangin; Cheryl Brunton; Lance Jennings; Lynn Fletcher
Journal:  Br J Gen Pract       Date:  2013-06       Impact factor: 5.386

5.  Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Authors:  Camille Pelat; Alessandra Falchi; Fabrice Carrat; Anne Mosnier; Isabelle Bonmarin; Clément Turbelin; Sophie Vaux; Sylvie van der Werf; Jean Marie Cohen; Bruno Lina; Thierry Blanchon; Thomas Hanslik
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

Review 6.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

7.  Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.

Authors:  Elisabeth G W Huijskens; Johan Reimerink; Paul G H Mulder; Janko van Beek; Adam Meijer; Erwin de Bruin; Ingrid Friesema; Menno D de Jong; Guus F Rimmelzwaan; Marcel F Peeters; John W A Rossen; Marion Koopmans
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.

Authors:  Wei Dong; Yoshita Bhide; Federica Sicca; Tjarko Meijerhof; Kate Guilfoyle; Othmar G Engelhardt; Louis Boon; Cornelis A M de Haan; George Carnell; Nigel Temperton; Jacqueline de Vries-Idema; David Kelvin; Anke Huckriede
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.